Hepatologist Dallas Fort Worth

The Liver Summit

Current Event

Directors

Thomas G. Cotter, MD MS

Chair

Medical Director, Texas Liver Care, and Director & Principal Investigator, Evidentis Clinical Research. Transplant hepatologist and obesity medicine specialist with a focus on alcohol-associated and metabolic liver disease.

Sumeet Asrani, MD Msc

Co-Director

Chief of Hepatology and Liver Transplantation at Baylor Scott & White and Medical Director of the Center for Advanced Liver Disease.

Participating Faculty

Mazen Noureddin, MD

Professor of Medicine at Houston Methodist and Weill Cornell Medicine and internationally recognized expert in steatotic liver disease, clinical trials, and therapeutic development.

Naim Alkhouri, MD

Medical Director of Research at the Clinical Research Institute of Ohio and internationally recognized expert in steatotic liver disease and clinical drug development.

Juan Pablo Arab, MD

Associate Professor of Medicine at Virginia Commonwealth University and Director of Alcohol Sciences at the Stravitz-Sanyal Institute, specializing in alcohol-associated and steatotic liver disease.

Michael Charlton, MBBS

Internationally recognized hepatologist and transplant physician with expertise in liver transplantation, steatotic liver disease, and clinical drug development.

Tonia Vinton, MD

Assistant Professor of Internal Medicine at UT Southwestern and President of the Dallas Obesity Society, specializing in obesity medicine, metabolic health, and preventive care.

Mack Mitchell, MD

Professor of Internal Medicine and former Vice President for Medical Affairs at UT Southwestern, specializing in alcohol-associated liver disease, alcohol use disorder, and steatotic liver disease.

Jeremy Louissaint, MD

Assistant Professor of Internal Medicine at UT Southwestern and transplant hepatologist specializing in advanced liver disease, with research focused on digital health and artificial intelligence.

Ashwini Mehta, DO

Transplant hepatologist and gastroenterologist at Methodist Dallas Medical Center specializing in autoimmune and cholestatic liver disease, cirrhosis, and liver transplantation.

Thomas Kerr, MD PhD

Associate Professor of Internal Medicine at UT Southwestern and transplant hepatologist specializing in advanced liver disease, viral hepatitis, and liver transplantation.

Scott Carlson, MD

Endocrinologist at Baylor Scott & White Health specializing in diabetes, obesity, metabolism, and cardiovascular risk reduction.

Ranjeeta Bahirwani, MD

Transplant hepatologist at Baylor Scott & White Health specializing in advanced liver disease, liver transplantation, and hepatocellular carcinoma.

Mohammad Qasim Khan, MD

Assistant Professor of Medicine at Western University and transplant hepatologist specializing in steatotic liver disease, liver transplantation, and cardiometabolic health.

Mazen Iskandar, MD

Bariatric and minimally invasive surgeon at Baylor Scott & White Health specializing in metabolic and bariatric surgery, robotic surgery, and complex abdominal wall reconstruction.

delgado-fabrizzio-184174-400×400.width-400

Fabrizzio Delgado, MD

Assistant Professor of Psychiatry at UT Southwestern and board-certified addiction psychiatrist specializing in alcohol and substance use disorders and complex psychiatric care.

Craig Rosenstengle, MD

Transplant hepatologist at Baylor Scott & White Health specializing in advanced liver disease, liver transplantation, and hepatobiliary malignancies.

Ahmad Anouti, MD

Pediatric gastroenterology fellow at UT Southwestern, liver transplant recipient, and nationally recognized patient advocate bridging clinical medicine, research, and lived experience.

Agenda

Saturday, September 26, 2026

Time	Program
7:30 AM – 8:30 AM	Breakfast and Registration Delta Marriott Foyer
Session 1 – Integrating Metabolic Health in Liver Care Moderator: Sumeet Asrani, MD, MSc \| Location: Delta Marriott Conference Room
8:30 AM – 8:55 AM	Weight Management in Liver Disease: Diet, Activity, and Obesity Pharmacotherapy Tonia Vinton, MD
8:55 AM – 9:20 AM	Endobariatrics & Bariatric Surgery in the GLP-1 Agonist Era Mazen Iskander, MD
9:20 AM – 9:45 AM	Practical Management Strategies for Diabetes, Hypertension, and Cardiovascular Risk Reduction Scott Carlson, MD
9:45 AM – 10:10 AM	Metabolic Health After Transplant: Preventing Weight Gain, Diabetes, and Cardiovascular Disease Mohammad Qasim Khan, MD
10:10 AM – 10:30 AM	Panel Discussion & Q&A
10:30 AM – 10:40 AM	Coffee Break Foyer
10:40 AM – 11:00 AM	Living the Journey: A Patient's Perspective on Liver Disease Ahmad Anouti, MD
11:00 AM – 11:30 AM	Coffee and Visit Exhibits Delta Marriott Foyer
11:30 AM – 12:15 PM	Industry-Supported Educational Symposium (Non-CME) Ashwini Mehta, DODelta Marriott Conference RoomIndustry-Sponsored EventSponsored by Madrigal Pharmaceuticals
12:15 PM – 12:45 PM	Lunch and Visit Exhibits Delta Marriott Foyer
Session 2 – Steatotic Liver Disease – The Clinical Spectrum & Future Directions Moderator: Mack Mitchell, MD
12:45 PM – 1:10 PM	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Impact & Evolving Concepts Naim Alkhouri, MD
1:10 PM – 1:35 PM	Metabolic Dysfunction-Associated Alcohol-Related Liver Disease (MetALD): Defining the Overlap Juan Pablo Arab, MD
1:35 PM – 2:00 PM	Alcohol Use Disorder and Disordered Eating in Liver Disease: Clinical Management Strategies Fabrizzio Delgado, MD
2:00 PM – 2:25 PM	Steatotic Liver Disease Drug Pipeline: Current Trials and Future Horizons Michael Charlton, MBBS
2:25 PM – 2:50 PM	How I Treat MASLD and MetALD: A Practical, Case-Based Approach Mazen Noureddin, MD
2:50 PM – 3:10 PM	Panel Discussion & Q&A
3:10 PM – 3:20 PM	Break and Visit Exhibits Foyer
Session 3 – General Hepatology UpdatesModerator: Mohammad Qasim Khan, MD
3:20 PM – 3:40 PM	Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Diagnosis and Treatment Updates Ashwini Mehta, DO
3:40 PM – 4:00 PM	Hepatocellular Carcinoma and Cholangiocarcinoma: Advances in Diagnosis and Management Craig Rosenstengle, MD
4:00 PM – 4:20 PM	Artificial Intelligence in Liver Care Jeremy Louissaint, MD
4:20 PM – 4:40 PM	Preventing Cirrhosis Complications: From Anticoagulation to Beta Blockers Ranjeeta Bahirwani, MD
4:40 PM – 5:00 PM	Viral Hepatitis in 2026: Practical Updates in Screening, HBV Management, and Cure Pathways Thomas Kerr, MD
5:00 PM	Closing Remarks and Networking Reception